Late Effects Working Group (LEAP)

NCCN’s LEAP Working Group monitors the delivery of the Late Effects Assessment Programme (LEAP) and provides recommendations for improvements. LEAP focuses on patients who have completed treatment and the bulk of their disease surveillance programme. It deals with the consequences of the treatment which was necessary to achieve cure of the cancer. This includes evaluating treatment related organ system dysfunction, reintegration into the community, and surveillance for second malignancy.

The Working Group aims to:

  • Improve national consistency in the delivery of LEAP
  • Develop information resources
  • Maintain best practice across LEAP
  • Ensure appropriate levels of resourcing to maintain a robust national Late Effects Assessment Programme.

For more information contact:

Kathy Yallop

Working Group Convenor

kyallop@adhb.govt.nz